Lexicon Drug Patent Portfolio
Lexicon owns 1 orange book drug protected by 3 US patents Given below is the list of Lexicon's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8217156 | Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use | 07 Oct, 2030 | Active |
| US8476413 | Sulfanyl-tetrahydropyran-based compounds and methods of their use | 29 May, 2028 | Active |
| US7781577 | Inhibitors of sodium glucose co-transporter 2 and methods of their use | 04 May, 2028 | Active |
Latest Legal Activities on Lexicon's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lexicon.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Withdrawal of Application for PTE | 14 Aug, 2025 | US8217156 |
| PTE *Waiver of time period for requesting reconsideration | 10 Jun, 2025 | US8217156 |
| Notice of Final Determination -Election Required | 28 May, 2025 | US8217156 |
| Notice of Final Determination -Election Required | 28 May, 2025 | US7781577 |
| FDA Final Eligibility Letter | 21 May, 2025 | US8217156 |
| FDA Final Eligibility Letter | 21 May, 2025 | US7781577 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 18 Dec, 2024 | US8476413 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 17 Dec, 2024 | US8476413 |
| transaction for FDA Determination of Regulatory Review Period | 11 Sep, 2024 | US8217156 |
| transaction for FDA Determination of Regulatory Review Period | 11 Sep, 2024 | US7781577 |
| transaction for FDA Determination of Regulatory Review Period | 08 Aug, 2024 | US8217156 |
| transaction for FDA Determination of Regulatory Review Period | 08 Aug, 2024 | US7781577 |
| Electronic Review | 01 Aug, 2024 | US7781577 |
| Change in Power of Attorney (May Include Associate POA) | 31 Jul, 2024 | US7781577 |
| Email Notification | 31 Jul, 2024 | US7781577 |
Lexicon's Family Patents
Lexicon Drug List
Given below is the complete list of Lexicon's drugs and the patents protecting them.
1. Inpefa
Inpefa is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8217156 | Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use |
07 Oct, 2030
(4 years from now)
| Active |
| US8476413 | Sulfanyl-tetrahydropyran-based compounds and methods of their use |
29 May, 2028
(2 years from now)
| Active |
| US7781577 | Inhibitors of sodium glucose co-transporter 2 and methods of their use |
04 May, 2028
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Inpefa's drug page